fda acts on cough drugs associated press washington manufacturers of unapproved extended release cough and cold drugs that contain an expectorant called guaifenesin have until nov to stop shipping the medicines health officials said the food and drug administration said roughly companies make hundreds of timed release medicines containing guaifenesin that have never undergone agency review they are expected to stop making the drugs even earlier by aug the drugs are sold both by prescription and over the counter and as both single ingredient and combination products fridays action doesnt affect products containing guaifenesin in immediate release form the fda said the agency said it knew of no safety issues with guaifenesin which has been used in medicines for decades only one company adams respiratory therapeutics inc currently has fda approval to sell extended release guaifenesin 
